HOME >> BIOLOGY >> NEWS
Gladstone scientists announce new version of bioinformatics software program

A team of scientists at the J. David Gladstone Institutes has unveiled a new version of GenMAPP, a widely used software program designed to help biomedical scientists view and analyze genome-scale data sets in the context of biological pathways.

GenMAPP 2.0, short for Gene Map Annotator and Pathway Profiler, marks the first major revision of the program, which was developed and launched by Gladstone scientists in 2002. With the program having been freely available at www.GenMAPP.org to all researchers since its debut, it has now become a standard means of depicting and sharing biological data and pathway information.

As GenMAPP developer Bruce Conklin, MD, points out, a single genomics experiment can yield enough data to fill a large telephone book, and methods for organizing and analyzing the data are desperately needed.

"Genomic experiments can easily overwhelm a scientist with data," explained Conklin, an investigator at the Gladstone Institute of Cardiovascular Disease and UCSF associate professor of medicine, molecular and cellular pharmacology. "GenMAPP organizes the data by biological process, a scheme that most biologists understand, and allows us to find new connections that we would not have seen otherwise."

From its beginnings, GenMAPP has been designed for viewing and analyzing gene expression data on biological pathways and other groupings of genes. GenMAPP 2.0 incorporates a variety of new features, many of them suggested by users, including:

  • A flexible format that accepts many different gene ID systems from resources for many species, including human, Drosophila (fruit fly), mouse, rat, zebrafish, C. elegans (a microscopic roundworm), and S. cerevisiae (yeast).

  • Species-specific gene databases that show relationships between the various gene ID systems in the database. For example, genes on the MAPP (GenMAPP files that represent biological pathways or groupings of genes) may use a single comm
    '"/>


Contact: John Watson
jwatson@gladstone.ucsf.edu
415-734-2019
University of California - San Francisco
1-Mar-2005


Page: 1 2

Related biology news :

1. Gladstones Deepak Srivastava receives E. Mead Johnson Award for achievement in pediatrics
2. Gladstone scientists identify critical gene factor in heart development
3. Gladstone scientists prove neurons produce Alzheimers-linked apolipoprotein E
4. Gladstone Institutes receives funding for training grant from stem cell institute
5. Gladstone researchers hone in on differentiation of heart stem cells
6. Gladstone study links Alzheimers with toxic protein fragments
7. Gladstone researchers identify new drug target for Alzheimers disease
8. Gladstone Institutes assists with Exploratorium stem cell exhibit
9. CIRM awards $2.4 million training grant to the Gladstone Institutes
10. Gladstone investigators discover how resting T cells avoid HIV infection
11. Gladstone investigator Steve Finkbeiner wins prestigious Lieberman Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/25/2016)... SEATTLE , Jan. 25, 2016  Glencoe Software, ... biotech, pharma and publication industries, will provide the data ... Phenotypic Screening Centre (NPSC). ... Phenotypic analysis ... even whole organisms, allowing comparisons between states such as ...
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... significant achievements are the result of the company,s laser ... iMedNet eClinical , it,s comprehensive, easy-to-use and highly ... --> Key MedNet growth achievements in 2015 ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical industry ... a host of launch activities including the identification and ... launch activity is especially high in the oncology therapeutic ... Best Practices and the Role of Medical Affairs in ... focused on oncology therapies find better ways to utilize ...
(Date:2/4/2016)... LEXINGTON, Massachusetts , February 4, 2016 - New ... --> - New FDA action date of July ... date of July 22, 2016   - ... the U.S. in the past decade indicated for the treatment of signs and ... Lifitegrast has the potential to be the only product approved in the ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech ... a leading provider of biopharmaceutical products in ... of its board of directors received on February 4, ... 2016, from a consortium comprised of PKU V-Ming ( ... Biomedicine Co., Ltd., CICC Qianhai Development ( Shenzhen ...
Breaking Biology Technology:
Cached News: